Medicover Integrated Clinical Services
Medicover Integrated Clinical Services is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
An Open-label study of patients with primary sclerosing cholangitis (PSC) treated with norucholic acid tablets
Sponsor Dr. Falk Pharma GmbH
- Start (EU)
- Latest update
- Estimated end
Pharmacokinetic/pharmacodynamic evaluation of ublituximab in patients with autoimmune diseases
Sponsor Tg Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1/2, Multicenter, Open-Label Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL310 in Pediatric Participants with Hunter Syndrome
Sponsor Denali Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
Sponsor Hansa Biopharma AB
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Medicover Integrated Clinical Services?
The 2026-10-09 snapshot links Medicover Integrated Clinical Services to 4 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Medicover Integrated Clinical Services?
The most frequently recorded therapeutic areas are Hepatology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Medicover Integrated Clinical Services conducted?
The linked trials record locations in 14 countries, including Netherlands, Austria, Belgium, Germany, France. These are trial locations, not confirmed office locations or countries where Medicover Integrated Clinical Services delivered services.
What can this page tell me about Medicover Integrated Clinical Services's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 2 recorded name variants under Medicover Integrated Clinical Services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Medicover Integrated Clinical Services
- Medicover Integrated Clinical Services GmbH